Connect with us

Nano Technology

Visualizing the growth process of sodium microstructures in sodium batteries by in-situ 23Na MRI and NMR spectroscopy

Avatar

Published

on

  • 1.

    Lee, B., Paek, E., Mitlin, D. & Lee, S. W. Sodium metal anodes: emerging solutions to dendrite growth. Chem. Rev. 119, 5416–5460 (2019).

    CAS  Article  Google Scholar 

  • 2.

    Zhao, Y. et al. In situ formation of highly controllable and stable Na3PS4 as a protective layer for Na metal anode. J. Mater. Chem. A 7, 4119–4125 (2019).

    CAS  Article  Google Scholar 

  • 3.

    Zheng, J. et al. Extremely stable sodium metal batteries enabled by localized high-concentration electrolytes. ACS Energy Lett. 3, 315–321 (2018).

    CAS  Article  Google Scholar 

  • 4.

    Luo, W. et al. Encapsulation of metallic Na in an electrically conductive host with porous channels as a highly stable Na metal anode. Nano Lett. 17, 3792–3797 (2017).

    CAS  Article  Google Scholar 

  • 5.

    Liu, S. et al. Porous Al current collector for dendrite-free Na metal anodes. Nano Lett. 17, 5862–5868 (2017).

    CAS  Article  Google Scholar 

  • 6.

    Zhou, W., Li, Y., Xin, S. & Goodenough, J. B. Rechargeable sodium all-solid-state battery. ACS Cent. Sci. 3, 52–57 (2017).

    CAS  Article  Google Scholar 

  • 7.

    Rodriguez, R. et al. In situ optical imaging of sodium electrodeposition: effects of fluoroethylene carbonate. ACS Energy Lett. 2, 2051–2057 (2017).

    CAS  Article  Google Scholar 

  • 8.

    Li, X., Zhao, L., Li, P., Zhang, Q. & Wang, M.-S. In-situ electron microscopy observation of electrochemical sodium plating and stripping dynamics on carbon nanofiber current collectors. Nano Energy 42, 122–128 (2017).

    CAS  Article  Google Scholar 

  • 9.

    Jin, Y. et al. Identifying the structural basis for the increased stability of the solid electrolyte interphase formed on silicon with the additive fluoroethylene carbonate. J. Am. Chem. Soc. 139, 14992–15004 (2017).

    CAS  Article  Google Scholar 

  • 10.

    Gao, L. et al. Revealing the chemistry of an anode-passivating electrolyte salt for high rate and stable sodium metal batteries. J. Mater. Chem. A 6, 12012–12017 (2018).

    CAS  Article  Google Scholar 

  • 11.

    Yu, C. et al. Accessing the bottleneck in all-solid state batteries, lithium-ion transport over the solid–electrolyte–electrode interface. Nat. Commun. 8, 1086 (2017).

    Article  Google Scholar 

  • 12.

    Bhattacharyya, R. et al. In situ NMR observation of the formation of metallic lithium microstructures in lithium batteries. Nat. Mater. 9, 504–510 (2010).

    CAS  Article  Google Scholar 

  • 13.

    Chandrashekar, S. et al. 7Li MRI of Li batteries reveals location of microstructural lithium. Nat. Mater. 11, 311–315 (2012).

    CAS  Article  Google Scholar 

  • 14.

    Chang, H. J. et al. Correlating microstructural lithium metal growth with electrolyte salt depletion in lithium batteries using 7Li MRI. J. Am. Chem. Soc. 137, 15209–15216 (2015).

    CAS  Article  Google Scholar 

  • 15.

    Kim, H. et al. Ethylene bis-carbonates as telltales of SEI and electrolyte health, role of carbonate type and new additives. Electrochim. Acta 136, 157–165 (2014).

    CAS  Article  Google Scholar 

  • 16.

    Komaba, S. et al. Electrochemical Na insertion and solid electrolyte interphase for hard-carbon electrodes and application to Na-ion batteries. Adv. Funct. Mater. 21, 3859–3867 (2011).

    CAS  Article  Google Scholar 

  • 17.

    Iermakova, D. I., Dugas, R., Palacin, M. R. & Ponrouch, A. On the comparative stability of Li and Na metal anode interfaces in conventional alkyl carbonate electrolytes. J. Electrochem. Soc. 162, A7060–A7066 (2015).

    CAS  Article  Google Scholar 

  • 18.

    Seh, Z. W., Sun, J., Sun, Y. & Cui, Y. A highly reversible room-temperature sodium metal anode. ACS Cent. Sci. 1, 449–455 (2015).

    CAS  Article  Google Scholar 

  • 19.

    Cao, R. et al. Enabling room temperature sodium metal batteries. Nano Energy 30, 825–830 (2016).

    CAS  Article  Google Scholar 

  • 20.

    Choudhury, S. et al. Designing solid-liquid interphases for sodium batteries. Nat. Commun. 8, 898 (2017).

    Article  Google Scholar 

  • 21.

    Wood, K. N. et al. Dendrites and pits: untangling the complex behavior of lithium metal anodes through operando video microscopy. ACS Cent. Sci. 2, 790–801 (2016).

    CAS  Article  Google Scholar 

  • 22.

    Yui, Y., Hayashi, M. & Nakamura, J. In situ microscopic observation of sodium deposition/dissolution on sodium electrode. Sci. Rep. 6, 22406 (2016).

    CAS  Article  Google Scholar 

  • 23.

    Zhao, C. et al. Advanced Na metal anodes. J. Energy Chem. 27, 1584–1596 (2018).

    Article  Google Scholar 

  • 24.

    Wu, B., Lochala, J., Taverne, T. & Xiao, J. The interplay between solid electrolyte interface (SEI) and dendritic lithium growth. Nano Energy 40, 34–41 (2017).

    CAS  Article  Google Scholar 

  • 25.

    Bayley, P. M., Trease, N. M. & Grey, C. P. Insights into electrochemical sodium metal deposition as probed with in situ 23Na NMR. J. Am. Chem. Soc. 138, 1955–1961 (2016).

    CAS  Article  Google Scholar 

  • 26.

    Cheng, X.-B., Yan, C., Zhang, X.-Q., Liu, H. & Zhang, Q. Electronic and ionic channels in working interfaces of lithium metal anodes. ACS Energy Lett. 3, 1564–1570 (2018).

    CAS  Article  Google Scholar 

  • 27.

    Reeve, Z. E. et al. Detection of electrochemical reaction products from the sodium-oxygen cell with solid-state 23Na NMR spectroscopy. J. Am. Chem. Soc. 139, 595–598 (2017).

    CAS  Article  Google Scholar 

  • 28.

    Wang, D. et al. The synergistic effects of Al and Te on the structure and Li+-mobility of garnet-type solid electrolytes. J. Mater. Chem. A 2, 20271–20279 (2014).

    CAS  Article  Google Scholar 

  • 29.

    Tian, Y. et al. Reactivity-guided interface design in Na metal solid-state batteries. Joule 3, 1037–1050 (2019).

    CAS  Article  Google Scholar 

  • 30.

    Zhang, X.-Q., Cheng, X.-B., Chen, X., Yan, C. & Zhang, Q. Fluoroethylene carbonate additives to render uniform Li deposits in lithium metal batteries. Adv. Funct. Mater. 27, 1605989 (2017).

    Article  Google Scholar 

  • 31.

    Jin, Y. et al. Understanding fluoroethylene carbonate and vinylene carbonate based electrolytes for Si anodes in lithium ion batteries with NMR spectroscopy. J. Am. Chem. Soc. 140, 9854–9867 (2018).

    CAS  Article  Google Scholar 

  • 32.

    Bray, J. M. et al. Operando visualisation of battery chemistry in a sodium-ion battery by 23Na magnetic resonance imaging. Nat. Commun. 11, 2083 (2020).

    CAS  Article  Google Scholar 

  • Source: https://www.nature.com/articles/s41565-020-0749-7

    Nano Technology

    Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease

    Avatar

    Published

    on

    Home > Press > Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease

    Abstract:
    – Serum Z-AAT reductions of 86-93%

    – All patients demonstrated greater than 80% reduction in liver Z-AAT monomer

    – 3 of 4 patients had a decrease in liver globule involvement

    – 3 of 4 patients demonstrated reductions in Z-AAT polymer with a range of 68-97%

    – All patients showed ALT reductions ranging from 36-66%

    Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease


    Pasadena. CA | Posted on November 13th, 2020

    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced positive interim clinical data from AROAAT2002, an open-label Phase 2 clinical study of ARO-AAT, the company’s second-generation investigational RNA interference (RNAi) therapeutic being developed as a treatment for the rare genetic liver disease associated with alpha-1 antitrypsin deficiency (AATD). The data demonstrate that three doses of ARO-AAT over 24-weeks resulted in consistent reductions of the disease-causing mutant Z protein (Z-AAT) and improvements in clinically relevant biomarkers of liver disease. The results were presented in a late-breaking poster at The Liver Meeting Digital Experience, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD).

    A copy of the poster may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.

    Javier San Martin, M.D., chief medical officer at Arrowhead, said: “These data presented at AASLD strongly suggest that ARO-AAT is doing what it’s designed to do, which is reduce the production of the misfolded mutant Z-AAT protein. Moreover, these compelling results indicate that the liver may have the ability to clear out accumulated Z-AAT and begin to heal itself faster than anticipated. Importantly, we saw reductions in serum Z-AAT and liver Z-AAT which led to improvements in multiple markers, such as liver globules, ALT/GGT and Pro-C3. These are all positive indications of a strong pharmacodynamic response and improvement in liver health, following just three doses of ARO-AAT. We anticipate data from additional patient cohorts will be available in the coming months, which will be included in our planned discussions with the U.S. Food and Drug Administration and other regulatory agencies, aimed at exploring areas where the ARO-AAT program could potentially be streamlined and accelerated.”

    In the AROAAT2002 study, four patients with homozygous PiZZ alpha-1 antitrypsin deficiency and evidence of fibrosis at screening, each received three doses of ARO-AAT on week 0, 4, and 16. Liver biopsies were performed at screening and at week 24. Assessments included safety (including pulmonary function tests), changes in serum Z-AAT, liver Z-AAT, ALT, GGT, Pro-C3, liver elastography (FibroScan®), and liver globule assessment. Additional histologic adjudication is ongoing.

    Key data presented include the following:

    Pharmacodynamic Response at 24 weeks

    Serum Z-AAT reductions were 86-93%
    Total intra-hepatic Z-AAT reductions were 72-95%
    All patients demonstrated greater than 80% reduction in liver Z-AAT monomer (soluble)
    3 of 4 patients demonstrated reductions in Z-AAT polymer (insoluble) with a range of 68-97%
    3 of 4 patients had a decrease in liver globule involvement and 1 subject remained unchanged
    All patients showed reductions in ALT (range 36-66%) and in GGT (range 43-58%)
    3 of 4 patients demonstrated a substantial reduction of greater than 20% in FibroScan® values
    3 of 4 patients showed greater than 30% reduction in serum Pro-C3, a marker of fibrogenesis
    Safety

    Overall, ARO-AAT 200 mg as a subcutaneous injection was well tolerated in PiZZ AATD subjects
    One treatment emergent SAE of Epstein bar virus related myocarditis was reported
    No treatment emergent AEs related to change in pulmonary status or pulmonary function were reported
    No clinically meaningful changes in ppFEV1 from baseline to Week 24 were observed
    In October 2020, Arrowhead and Takeda Pharmaceutical Company Limited announced a collaboration and licensing agreement to develop ARO-AAT. Under the terms of the agreement, Arrowhead and Takeda will co-develop ARO-AAT which, if approved, will be co-commercialized in the U.S. under a 50/50 profit-sharing structure. Outside the U.S., Takeda will lead the global commercialization strategy and receive an exclusive license to commercialize ARO-AAT with Arrowhead eligible to receive tiered royalties of 20-25% on net sales. Arrowhead will receive an upfront payment of $300 million and is eligible to receive potential development, regulatory and commercial milestones up to $740 million. Closing of the transaction is contingent on completion of review under antitrust laws, including the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in the U.S.

    AROAAT2002 (NCT03946449) is a pilot open-label, multi-dose, Phase 2 study to assess the response to ARO-AAT in approximately 16 patients with AATD associated liver disease and baseline liver fibrosis who will be enrolled in three cohorts. All eligible participants will require a pre-dose biopsy and an end of study biopsy. Treated participants will also be offered the opportunity to continue treatment in an open-label extension (OLE). Including the OLE, interim assessments will be made after 6 months and 18 months (cohorts 1, 1b), and 12 months and 24 months (cohort 2) of treatment with ARO-AAT. Arrowhead is also evaluating ARO-AAT in the ongoing SEQUOIA Phase 2/3 trial, which began in August 2019.

    ####

    About Arrowhead Pharmaceuticals, Inc.
    Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

    For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company’s email list and receive news directly, please visit http://ir.arrowheadpharma.com/email-alerts .

    Safe Harbor Statement under the Private Securities Litigation Reform Act:

    This news release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the safety and efficacy of our product candidates, the duration and impact of regulatory delays in our clinical programs, our ability to finance our operations, the likelihood and timing of the receipt of future milestone and licensing fees, the future success of our scientific studies, our ability to successfully develop and commercialize drug candidates, the timing for starting and completing clinical trials, rapid technological change in our markets, and the enforcement of our intellectual property rights. Our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q discuss some of the important risk factors that may affect our business, results of operations and financial condition. We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances.

    For more information, please click here

    Contacts:
    Arrowhead Pharmaceuticals, Inc.
    Vince Anzalone, CFA
    626-304-3400

    Investors:
    LifeSci Advisors, LLC
    Brian Ritchie
    212-915-2578
    www.lifesciadvisors.com

    Media:
    LifeSci Communications, LLC
    Josephine Belluardo, Ph.D.
    646-751-4361
    www.lifescicommunications.com

    Copyright © Arrowhead Pharmaceuticals, Inc.

    If you have a comment, please Contact us.

    Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

    Bookmark:
    Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

    Related News Press

    News and information

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance November 13th, 2020

    CCNY & partners in quantum algorithm breakthrough November 13th, 2020

    Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020 November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    Govt.-Legislation/Regulation/Funding/Policy

    Making 3-D Nanosuperconductors with DNA: Complex 3-D nanoscale architectures based on DNA self-assembly can conduct electricity without resistance and may provide a platform for fabricating quantum computing and sensing devices November 10th, 2020

    Breakthrough quantum-dot transistors create a flexible alternative to conventional electronics: Quantum dot logic circuits provide the long-sought building blocks for innovative devices, including printable electronics, flexible displays, and medical diagnostics October 30th, 2020

    Face mask aims to deactivate virus to protect others: Antiviral layer attacks respiratory droplets to make mask wearer less infectious October 30th, 2020

    Flash graphene rocks strategy for plastic waste: Rice University lab detours potential environmental hazard into useful material October 30th, 2020

    Nanomedicine

    Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020 November 13th, 2020

    Making 3-D Nanosuperconductors with DNA: Complex 3-D nanoscale architectures based on DNA self-assembly can conduct electricity without resistance and may provide a platform for fabricating quantum computing and sensing devices November 10th, 2020

    ‘Electronic skin’ promises cheap and recyclable alternative to wearable devices November 10th, 2020

    Jet-printing microfluidic devices on demand November 6th, 2020

    Announcements

    Manchester group discover new family of quasiparticles in graphene-based materials: Findings to help achieve Holy Grail of 2D materials – superfast electronic devices November 13th, 2020

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance November 13th, 2020

    CCNY & partners in quantum algorithm breakthrough November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    Nanobiotechnology

    Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020 November 13th, 2020

    Making 3-D Nanosuperconductors with DNA: Complex 3-D nanoscale architectures based on DNA self-assembly can conduct electricity without resistance and may provide a platform for fabricating quantum computing and sensing devices November 10th, 2020

    Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 November 6th, 2020

    Jet-printing microfluidic devices on demand November 6th, 2020

    Source: http://www.nanotech-now.com/news.cgi?story_id=56429

    Continue Reading

    Nano Technology

    Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020

    Avatar

    Published

    on

    Home > Press > Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020

    Abstract:
    – ARO-APOC3 achieved triglyceride reductions of 74-92%

    – ARO-ANG3 achieved triglyceride reductions of 29-75% and LCL-C reductions of 29-35%

    – Company to host upcoming KOL webinars on ARO-APOC3 and ARO-ANG3

    Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020


    Pasadena. CA | Posted on November 13th, 2020

    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced positive clinical data from multiple product candidates in its cardiometabolic pipeline at the American Heart Association (AHA) Scientific Sessions 2020.

    Javier San Martin, M.D., chief medical officer at Arrowhead, said: “The data presented at AHA on our cardiometabolic pipeline continue to show strong and consistent response across a range of lipid parameters. There remains significant residual cardiovascular risk despite recent scientific advances, and we believe that our cardiometabolic pipeline has the ability to target new therapeutic targets and address multiple lipid parameters associated with increased cardiovascular risk.”

    Copies of the following presentations may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website:

    Title: Pharmacodynamic effect of ARO-ANG3, an investigational RNA interference therapeutic targeting hepatic angiopoietin-like protein 3, in patients with hypercholesterolemia
    Authors: Gerald F. Watts, et al.
    Session: Advances in Understanding and Treatment of Dyslipidemia and New Therapies for CVD

    Title: Pharmacodynamic effect of ARO-APOC3, an investigational hepatocyte-targeted RNA interference therapeutic targeting apolipoprotein C3, in patients with hypertriglyceridemia and multifactorial chylomicronemia
    Authors: Christie Ballantyne, presenting on behalf of Peter Clifton, et al.
    Session: Advances in Understanding and Treatment of Dyslipidemia and New Therapies for CVD

    Title: Safety, Tolerability and Efficacy of Single-Dose AMG 890, a Novel siRNA Targeting Lp(a), in Healthy Subjects and Subjects with Elevated Lp(a)
    Authors: Michael J. Koren, et al.
    Session: Advances in Understanding and Treatment of Dyslipidemia and New Therapies for CVD

    Arrowhead will also host two key opinion leader (KOL) webinars on November 18, and November 19, 2020 to discuss data from, and the company’s future plans for, its two investigational cardiometabolic candidates, ARO-APOC3 and ARO-ANG3. The webinars may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.

    ####

    About Arrowhead Pharmaceuticals, Inc.
    Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

    For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company’s email list and receive news directly, please visit http://ir.arrowheadpharma.com/email-alerts .

    Safe Harbor Statement under the Private Securities Litigation Reform Act:

    This news release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the safety and efficacy of our product candidates, the duration and impact of regulatory delays in our clinical programs, our ability to finance our operations, the likelihood and timing of the receipt of future milestone and licensing fees, the future success of our scientific studies, our ability to successfully develop and commercialize drug candidates, the timing for starting and completing clinical trials, rapid technological change in our markets, and the enforcement of our intellectual property rights. Our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q discuss some of the important risk factors that may affect our business, results of operations and financial condition. We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances.

    For more information, please click here

    Contacts:
    Arrowhead Pharmaceuticals, Inc.
    Vince Anzalone, CFA
    626-304-3400

    Investors:
    LifeSci Advisors, LLC
    Brian Ritchie
    212-915-2578
    www.lifesciadvisors.com

    Media:
    LifeSci Communications, LLC
    Josephine Belluardo, Ph.D.
    646-751-4361
    www.lifescicommunications.com

    Copyright © Arrowhead Pharmaceuticals, Inc.

    If you have a comment, please Contact us.

    Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

    Bookmark:
    Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

    Related News Press

    News and information

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance November 13th, 2020

    CCNY & partners in quantum algorithm breakthrough November 13th, 2020

    Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    Nanomedicine

    Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease November 13th, 2020

    Making 3-D Nanosuperconductors with DNA: Complex 3-D nanoscale architectures based on DNA self-assembly can conduct electricity without resistance and may provide a platform for fabricating quantum computing and sensing devices November 10th, 2020

    ‘Electronic skin’ promises cheap and recyclable alternative to wearable devices November 10th, 2020

    Jet-printing microfluidic devices on demand November 6th, 2020

    Announcements

    Manchester group discover new family of quasiparticles in graphene-based materials: Findings to help achieve Holy Grail of 2D materials – superfast electronic devices November 13th, 2020

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance November 13th, 2020

    CCNY & partners in quantum algorithm breakthrough November 13th, 2020

    Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease November 13th, 2020

    Events/Classes

    CEA-Leti to Present Latest Results & Insights on 3D Technologies, Power Electronics & Quantum Computing: Institute’s Experts to Host Online Tutorial on Qubit Figures of Merit And Short Course on 3D Sequential Integration November 9th, 2020

    Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 November 6th, 2020

    Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Year End Results November 3rd, 2020

    GLOBALFOUNDRIES Global Technology Conference 2020 China to Spotlight Innovations Accelerating the Digital Future: An engaging virtual event of insightful discussions and networking opportunities with thought leaders on future innovations November 2nd, 2020

    Nanobiotechnology

    Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease November 13th, 2020

    Making 3-D Nanosuperconductors with DNA: Complex 3-D nanoscale architectures based on DNA self-assembly can conduct electricity without resistance and may provide a platform for fabricating quantum computing and sensing devices November 10th, 2020

    Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 November 6th, 2020

    Jet-printing microfluidic devices on demand November 6th, 2020

    Source: http://www.nanotech-now.com/news.cgi?story_id=56430

    Continue Reading

    Nano Technology

    CCNY & partners in quantum algorithm breakthrough

    Avatar

    Published

    on

    Home > Press > CCNY & partners in quantum algorithm breakthrough

    The Google Quantum Computer. Photo courtesy of Google Quantum AI
    The Google Quantum Computer. Photo courtesy of Google Quantum AI

    Abstract:
    Researchers led by City College of New York physicist Pouyan Ghaemi report the development of a quantum algorithm with the potential to study a class of many-electron quantums system using quantum computers. Their paper, entitled “Creating and Manipulating a Laughlin-Type ν=1/3 Fractional Quantum Hall State on a Quantum Computer with Linear Depth Circuits,” appears in the December issue of PRX Quantum, a journal of the American Physical Society.

    CCNY & partners in quantum algorithm breakthrough


    New York, NY | Posted on November 13th, 2020

    “Quantum physics is the fundamental theory of nature which leads to formation of molecules and the resulting matter around us,” said Ghaemi, assistant professor in CCNY’s Division of Science. “It is already known that when we have a macroscopic number of quantum particles, such as electrons in the metal, which interact with each other, novel phenomena such as superconductivity emerge.”

    However, until now, according to Ghaemi, tools to study systems with large numbers of interacting quantum particles and their novel properties have been extremely limited.

    “Our research has developed a quantum algorithm which can be used to study a class of many-electron quantum systems using quantum computers. Our algorithm opens a new venue to use the new quantum devices to study problems which are quite challenging to study using classical computers. Our results are new and motivate many follow up studies,” added Ghaemi.

    On possible applications for this advancement, Ghaemi, who’s also affiliated with the Graduate Center, CUNY noted: “Quantum computers have witnessed extensive developments during the last few years. Development of new quantum algorithms, regardless of their direct application, will contribute to realize applications of quantum computers.

    “I believe the direct application of our results is to provide tools to improve quantum computing devices. Their direct real-life application would emerge when quantum computers can be used for daily life applications.”

    ###

    His collaborators included scientists from: Western Washington University, University of California, Santa Barbara; Google AI Quantum and the University of Michigan, Ann Arbor.

    ####

    For more information, please click here

    Contacts:
    Jay Mwamba
    917-892-0374

    Copyright © City College of New York

    If you have a comment, please Contact us.

    Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

    Bookmark:
    Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

    Related News Press

    News and information

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance November 13th, 2020

    Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020 November 13th, 2020

    Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    Quantum Physics

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    A new candidate material for quantum spin liquids November 12th, 2020

    Making 3-D Nanosuperconductors with DNA: Complex 3-D nanoscale architectures based on DNA self-assembly can conduct electricity without resistance and may provide a platform for fabricating quantum computing and sensing devices November 10th, 2020

    Quantum chemistry

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    A new candidate material for quantum spin liquids November 12th, 2020

    Possible Futures

    Manchester group discover new family of quasiparticles in graphene-based materials: Findings to help achieve Holy Grail of 2D materials – superfast electronic devices November 13th, 2020

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    A new candidate material for quantum spin liquids November 12th, 2020

    Quantum Computing

    A new candidate material for quantum spin liquids November 12th, 2020

    Making 3-D Nanosuperconductors with DNA: Complex 3-D nanoscale architectures based on DNA self-assembly can conduct electricity without resistance and may provide a platform for fabricating quantum computing and sensing devices November 10th, 2020

    CEA-Leti to Build Quantum-Photonics Platform to Ensure Ultra-Secure Data for Finance, Energy, Defense and Other Industries : Project Will Build Demonstrators for Transmitting and Receiving Qubits and Focus on Integrating the Technology in a Unique Platform to Address Quantum Comp October 30th, 2020

    Time crystals lead researchers to future computational work October 23rd, 2020

    Discoveries

    Manchester group discover new family of quasiparticles in graphene-based materials: Findings to help achieve Holy Grail of 2D materials – superfast electronic devices November 13th, 2020

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    A new candidate material for quantum spin liquids November 12th, 2020

    Announcements

    Manchester group discover new family of quasiparticles in graphene-based materials: Findings to help achieve Holy Grail of 2D materials – superfast electronic devices November 13th, 2020

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance November 13th, 2020

    Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

    Manchester group discover new family of quasiparticles in graphene-based materials: Findings to help achieve Holy Grail of 2D materials – superfast electronic devices November 13th, 2020

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    A new candidate material for quantum spin liquids November 12th, 2020

    Quantum nanoscience

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    A new candidate material for quantum spin liquids November 12th, 2020

    Making 3-D Nanosuperconductors with DNA: Complex 3-D nanoscale architectures based on DNA self-assembly can conduct electricity without resistance and may provide a platform for fabricating quantum computing and sensing devices November 10th, 2020

    Time crystals lead researchers to future computational work October 23rd, 2020

    Source: http://www.nanotech-now.com/news.cgi?story_id=56431

    Continue Reading

    Nano Technology

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance

    Avatar

    Published

    on

    Home > Press > Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance

    © Wiley-VCH, re-use with credit to 'Angewandte Chemie' and a link to the original article.
    © Wiley-VCH, re-use with credit to ‘Angewandte Chemie’ and a link to the original article.

    Abstract:
    Metal-ion hybrid capacitors combine the properties of capacitors and batteries. One electrode uses the capacitive mechanism, the other the battery-type redox processes. Scientists have now scrutinized the role of anions in the electrolyte. The results, which have been published in the journal Angewandte Chemie, reveal the importance of sulfate anions. Sulfate-based electrolytes gave zinc-ion hybrid capacitors outstanding performance and extra-long operability.

    Anions matter: Zinc-ion hybrid capacitors with ideal anions in the electrolyte show extra-long performance


    Heidelberg, Germany | Posted on November 13th, 2020

    Capacitors can uptake and release an enormous amount of charge in a short time, whereas batteries can store a lot of energy in a small volume. To combine both properties, scientists are investigating hybrid electrochemical cells, which contain both capacitor- and battery-type electrodes. Among these cells, researchers have identified metal-ion hybrid capacitors as especially promising devices. Here, the positive electrode includes pseudocapacitive properties, which means it can also store energy in the manner of a battery, by intercalation of the metal ions, while the negative electrode is made of a redox-active metal.

    However, their electrolyte has long been neglected, says Chunyi Zhi who is investigating battery materials together with his team at the City University of Hong Kong. The researchers believe the type of electrolyte anion affects the performance of the device. “Paying more attention to the introduction of appropriate anions can effectively improve the power and energy density of a capacitor,” they say.

    The researchers focused their attention on zinc-ion capacitors. This cell type consists of a zinc metal anode and a cathode made of titanium nitride nanofibers. The nanofibers are robust, and their porous surface allows the electrolyte to infiltrate. The scientists argue that the electrolyte anions, when attached to the titanium nitride surface, make the material more conductive. Moreover, the adsorbed anions may directly contribute to the charging process. The charging of the hybrid capacitor involves the extraction of the intercalated zinc ions.

    Zhi and his colleagues compared the effects of three electrolyte anions: sulfate, acetate, and chloride. They looked at both their binding to the electrode surface and the performances of the electrochemical cells. It was a clear result.

    The scientists reported that the sulfate anions stood out among the three anions. They observed that cells based on a zinc sulfate electrolyte performed best, and the sulfates bound stronger to the titanium nitride surface than the other anions. Moreover, sulfate-treated electrodes showed the lowest self-discharging. The authors attributed the findings to the electronic effects of sulfate. Its electron-pulling nature provides tight binding to the surface atoms and prevents the electrode from self-discharging, the authors concluded.

    For a zinc-sulfate-based zinc-ion hybrid capacitor, the scientists reported high-performance operation for more than nine months. Moreover, these devices are flexible, which is especially useful for portable electronics. The scientists tested the device in an electronic watch and found excellent performance.

    ###

    About the Author

    Dr. Chunyi Zhi is a Professor at the Department of Materials Science & Engineering at the City University of Hong Kong. His research interests span the practical application of flexible energy-storage devices, zinc-based batteries with new electrode materials and electrolytes, and catalysts for oxygen and nitrogen reduction reactions.

    http://www.comfortablenergy.net/

    ####

    For more information, please click here

    Contacts:
    Mario Mueller

    Copyright © Wiley

    If you have a comment, please Contact us.

    Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

    Bookmark:
    Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

    Related News Press

    News and information

    CCNY & partners in quantum algorithm breakthrough November 13th, 2020

    Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020 November 13th, 2020

    Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    Possible Futures

    Manchester group discover new family of quasiparticles in graphene-based materials: Findings to help achieve Holy Grail of 2D materials – superfast electronic devices November 13th, 2020

    CCNY & partners in quantum algorithm breakthrough November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    A new candidate material for quantum spin liquids November 12th, 2020

    Discoveries

    Manchester group discover new family of quasiparticles in graphene-based materials: Findings to help achieve Holy Grail of 2D materials – superfast electronic devices November 13th, 2020

    CCNY & partners in quantum algorithm breakthrough November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    A new candidate material for quantum spin liquids November 12th, 2020

    Announcements

    Manchester group discover new family of quasiparticles in graphene-based materials: Findings to help achieve Holy Grail of 2D materials – superfast electronic devices November 13th, 2020

    CCNY & partners in quantum algorithm breakthrough November 13th, 2020

    Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

    Manchester group discover new family of quasiparticles in graphene-based materials: Findings to help achieve Holy Grail of 2D materials – superfast electronic devices November 13th, 2020

    CCNY & partners in quantum algorithm breakthrough November 13th, 2020

    Smaller than Ever—Exploring the Unusual Properties of Quantum-sized Materials November 13th, 2020

    A new candidate material for quantum spin liquids November 12th, 2020

    Battery Technology/Capacitors/Generators/Piezoelectrics/Thermoelectrics/Energy storage

    Order in the disorder: density fluctuations in amorphous silicon discovered October 30th, 2020

    Making disorder for an ideal battery: Manufacturing safer, more powerful batteries that use geopolitically stable resources requires solid electrolytes and replacing lithium with sodium. A chemical solution is now being offered to battery developers. October 16th, 2020

    Fast calculation dials in better batteries: Analytical model from Rice University helps researchers fine-tune battery performance September 16th, 2020

    Boundaries no barrier for thermoelectricity: Rice researchers find potentially useful electrical phenomenon in gold nanowires September 8th, 2020

    Source: http://www.nanotech-now.com/news.cgi?story_id=56432

    Continue Reading
    Energy9 hours ago

    Ballard Closes US$402.5 Million Bought Deal Offering of Common Shares

    Energy9 hours ago

    Lithium-ion Battery Market Size USD 129.3 Billion By 2027 At A CAGR of 18.0% | Valuates Reports

    Energy9 hours ago

    CBAK Energy and Kandi Group Signed Supply Framework Agreement

    Energy10 hours ago

    Level Sensors Market worth $6.1 billion by 2025 – Exclusive Report by MarketsandMarkets™

    Energy10 hours ago

    Rescheduling of Work Commitments in Corentyne Block, Guyana

    Cyber Security11 hours ago

    Technological Innovations at the Tokyo Olympics

    Gaming14 hours ago

    The Basics: Popular Casino Games You Should Play

    Press Releases15 hours ago

    The International Vaccine Institute Supports a Global Campaign to Reduce the Spread of Covid-19

    Esports16 hours ago

    T1 re-signs top laner Canna, extends contract until 2022

    Energy16 hours ago

    JinkoSolar to Report Third Quarter 2020 Results on December 7, 2020

    Energy16 hours ago

    EWPG Holding AB: Interim report for the period 1 January – 30 September 2020

    Esports17 hours ago

    Khan joins DAMWON as team’s new top laner

    Cyber Security18 hours ago

    Different ways tech plays a key role in securing igaming platforms

    Energy22 hours ago

    LONGi suministra 273MW de sus módulos solares a la mayor planta solar del Sureste de Asia

    Ecommerce23 hours ago

    ADvendio Celebrates 10 Years of Product Excellence and Growth

    Esports24 hours ago

    Super Smash Bros. Melee Slippi mod launches broadcast feature early in response to #FreeMelee

    Esports24 hours ago

    The 7 best low-back gaming chairs

    Denmark
    Esports24 hours ago

    Heroic move past Endpoint in BLAST Premier Showdown

    Esports1 day ago

    Na’Vi brings Mag back from inactive roster to coach Dota 2 team

    Esports1 day ago

    Fantasy games live for DreamHack Masters Winter and Flashpoint 2 playoffs

    Energy1 day ago

    Worldwide Hybrid Diesel Genset Industry to 2026 – Key Drivers and Restraints

    Energy1 day ago

    The Neutrino Energy Group Transcends the Theoretical to Transform Practical Energy Use Worldwide

    Esports1 day ago

    How to activate crossplay on Rainbow Six Siege

    Esports1 day ago

    Pokémon teases 25th-anniversary celebration during Macy’s Thanksgiving Day Parade

    Energy1 day ago

    ChemPoint es seleccionado como distribuidor de los productos de Soluciones Especializadas de DuPont para México

    Esports1 day ago

    Apex Legends Dev Believes Wattson Isn’t ‘Useless’

    Esports1 day ago

    Horizon Voice Actor Shows What it Was Like to Record During the Pandemic

    United States
    Esports1 day ago

    Liquid edge past MAD Lions in BLAST Premier Fall Showdown

    Energy1 day ago

    Europe Excavator Market Outlook Report 2020-2025 Featuring Prominent Players – Caterpillar, CNH, John Deere, Kobelco, Liebherr

    Esports1 day ago

    League’s original 17 champions and how different they were 11 years ago

    Trending